Xiang R - Search Results

1

The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.

Imboden M, Murphy KR, Rakhmilevich AL, Neal ZC, Xiang R, Reisfeld RA, Gillies SD, Sondel PM. Imboden M, et al. Among authors: xiang r. Cancer Res. 2001 Feb 15;61(4):1500-7. Cancer Res. 2001. PMID: 11245457

2

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

Xiang R, Lode HN, Dolman CS, Dreier T, Varki NM, Qian X, Lo KM, Lan Y, Super M, Gillies SD, Reisfeld RA. Xiang R, et al. Cancer Res. 1997 Nov 1;57(21):4948-55. Cancer Res. 1997. PMID: 9354462

3

Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.

Xiang R, Lode HN, Dreier T, Gillies SD, Reisfeld RA. Xiang R, et al. Cancer Res. 1998 Sep 1;58(17):3918-25. Cancer Res. 1998. PMID: 9731503

4

Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapy.

Dolman CS, Mueller BM, Lode HN, Xiang R, Gillies SD, Reisfeld RA. Dolman CS, et al. Among authors: xiang r. Clin Cancer Res. 1998 Oct;4(10):2551-7. Clin Cancer Res. 1998. PMID: 9796990

5

MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.

Ruehlmann JM, Xiang R, Niethammer AG, Ba Y, Pertl U, Dolman CS, Gillies SD, Reisfeld RA. Ruehlmann JM, et al. Among authors: xiang r. Cancer Res. 2001 Dec 1;61(23):8498-503. Cancer Res. 2001. PMID: 11731434

6

A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.

Luo Y, Zhou H, Mizutani M, Mizutani N, Liu C, Xiang R, Reisfeld RA. Luo Y, et al. Among authors: xiang r. Cancer Res. 2005 Apr 15;65(8):3419-27. doi: 10.1158/0008-5472.CAN-04-3120. Cancer Res. 2005. PMID: 15833877

7

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.

Lode HN, Xiang R, Varki NM, Dolman CS, Gillies SD, Reisfeld RA. Lode HN, et al. Among authors: xiang r. J Natl Cancer Inst. 1997 Nov 5;89(21):1586-94. doi: 10.1093/jnci/89.21.1586. J Natl Cancer Inst. 1997. PMID: 9362156

8

T cell memory against colon carcinoma is long-lived in the absence of antigen.

Xiang R, Lode HN, Gillies SD, Reisfeld RA. Xiang R, et al. J Immunol. 1999 Oct 1;163(7):3676-83. J Immunol. 1999. PMID: 10490962

9

Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.

Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA. Xiang R, et al. Clin Cancer Res. 2001 Mar;7(3 Suppl):856s-864s. Clin Cancer Res. 2001. PMID: 11300483

10

Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.

Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA. Niethammer AG, et al. Among authors: xiang r. Cancer Res. 2001 Aug 15;61(16):6178-84. Cancer Res. 2001. PMID: 11507070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,130 results

Search Page

Filters